Understanding the crisis in harm reduction funding in Central and Eastern Europe

Table 3 Developments in funding from the national budgets in the Czech Republic (2005–2018, in thousands of EUR)

Source	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018
ADF/Subvention from Government office in total (CR)	3547	3838	3762	4008	3686	3381	3695	3599	3690	3385	3482	4659	5428	7362
Harm reduction	n.a	n.a	1765	1952	1840	1744	1950	1911	1887	1804	1789	2194	2267	3064
MoH in total (? in CR)	1124	635	801	757	569	849	861	746	570	857	918	777	1368	1681
Harm reduction	n.a	n.a	105	159	163	64	79	150	195	156	293	367	503	739
MoLSA (? in CR)	1546	1753	2054	3186	3282	3628	3129	3355	3713	5195	5889	6857	7870	11,371
Harm reduction	n.a	n.a	1193	1808	1839	2013	1697	1809	2046	2342	2623	3241	3481	4524
HR Total in CR	n.a	n.a	3063	3919	3842	3821	3726	3870	4128	4302	4705	5801	6252	8327

Developments in the funding of drug services in total and HR services specifically provided from the respective national budgets. Analysis of financial support provided from the respective budgets of the Government Council for Drug Policy Coordination (Government office), Ministry of Health (MoH), and Ministry of Labour and Social Affairs (MoLSA)
Average exchange rates in the respective years were used for the re-calculation of expenses from CZK to EUR

ISSN: 1477-7517